contract_awardAwarded Friday, September 4, 2026Analyzed

DEPARTMENT OF BEHAVIORAL HEALTH & DEVELOPMENTAL SERVICES: $82.3M Department of Health and Human Services Grant

Neutral

Summary

The $82.3M grant to the Virginia Department of Behavioral Health & Developmental Services continues the state's opioid response program. No publicly traded company is directly involved, so the market impact is limited to sector-level tailwinds for healthcare services related to substance abuse treatment.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The $82.3M grant is a routine renewal for Virginia's opioid response program, not a new competitive award.
  • 2.No publicly traded company is directly impacted; the contract benefits state and local healthcare providers.
  • 3.Investors should monitor broader federal healthcare spending bills, but this specific award does not create a stock catalyst.

Market Implications

The contract has no direct market implications for publicly traded companies. The opioid response funding is a continuation of existing programs and does not represent new business for any listed entity. Investors in healthcare ETFs may see indirect support from sustained federal spending on substance abuse treatment, but no single stock is positioned to benefit from this award.

Full Analysis

The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded an $82.3M project grant to the Virginia Department of Behavioral Health & Developmental Services (DBHDS) for its State Opioid Response (SOR) program. The grant covers three years (2024-2027) with $27.3M per year. DBHDS will distribute funds to community-based and faith-based organizations, universities, free clinics, and federally qualified health clinics across Virginia. Since the recipient is a state government entity, no publicly traded company is the direct beneficiary. However, the contract signals continued federal commitment to opioid crisis funding, which supports the broader healthcare sector, particularly substance abuse treatment providers. Related legislation such as the Campus Lifeline Act and Indian Health Needs Act aligns with this trend but does not directly fund this grant. Without a public company recipient, supply chain effects are diffuse and not attributable to specific tickers. Historically, similar SAMHSA grants have provided stable funding for state behavioral health systems without creating direct stock catalysts.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Contract Details

Recipient

DEPARTMENT OF BEHAVIORAL HEALTH & DEVELOPMENTAL SERVICES

Award Amount

$82,326,354

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Related Bills

HR8657HR741S4400

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →